APOE and cancer: In the overall cancer group (EH + ECa and ECa), APOE E 2 allele was more frequent among patients compared with controls, but the results were nonsignificant after multiple testing corrections (P = 0.036, PBonferroni > 0.05, OR = 1.54, 95% CI 1.03–2.30).